Ömür ERKIZAN, Sibel BİLGİLİ, Çelebiler Aydan ÇAVUŞOĞLU, Huriye ARICAN, Baysal KARACA

Thyroid hormone reference intervals and the prevalence of thyroid antibodies

To establish new reference intervals for thyrotropin (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) on the Beckman Coulter DxI 800 in healthy Turkish adults and assess the prevalence of laboratory evidence of thyroid antibodies in this population. Materials and methods: Specimens were obtained from 619 healthy volunteers (338 females, 281 males).The study was conducted with health care professionals and their relatives, The mean age of all the subjects was 34.7 and the median was 31 years, with ages ranging from 15 to 84. Moreover, the subjects had no evidence of thyroid autoimmunity or a history of drug use, both of which might interfere with thyroid function. Results: After exclusion of samples positive for thyroid antibodies (Antithyroperoxidase; TPOAb, Antithyroglobulin; TgAb), the final sample size for the evaluation of TSH, FT3, and FT4 reference ranges was 509 (254 females, 255 males) and the age range was 15-80 (mean 34.1, median 30). The prevalence of antithyroid antibodies was 17.8% in total and positive thyroid antibodies were more common among females (13.6%) than males (4.2%). We established the reference intervals for the healthy adults as 0.41-4.25 mIU/L for TSH, 0.61-1.06 ng/dL (7.85-13.64 pmol/L) for FT4, and 2.62-3.84 pg/mL (4.02-5.90 pmol/L) for FT3. Conclusion: The reference intervals of thyroid hormones vary considerably from those of other populations and the intervals recommended by the manufacturer. This underlines the need for population-specific reference ranges.

Anahtar Kelimeler:

Key words: Reference intervals, thyroid antibodies, thyrotropin, free thyroxine, free triiodothyronine

Thyroid hormone reference intervals and the prevalence of thyroid antibodies

Keywords:

Key words: Reference intervals, thyroid antibodies, thyrotropin, free thyroxine, free triiodothyronine,

PDF

___

Dixon WJ. Processing data for outliers. Biometrics 1953; 9: 74- 89.
Campbell MJ, Gardner MJ (1988). Calculating confidence intervals for some non-parametric analyses. British Medical Journal, 1988; 296: 1454-6.
Ilcol YO, Aslan D. Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey. Clin Chem Lab Med. 2006;44: 867-76
Atalay AC, Karaman MI, Güney S, Dalkiliç A, Müslümano lu AY, Ergenekon E. Age-specific PSA reference ranges in a group of non-urologic patients. Int Urol Nephrol. 1998; 30: 587-91.
Friis-Hansen L and Hilsted L. Reference intervals for thyreotropin and thyroid hormones for healthy adults based on the NOBIDA material and determined using a Modular E170.Clin Chem Lab Med 2008; 46: 1305-12.
Danbaek L, Jorgensen LM. Screening for thyroid disease. Occurrence of hypothyroidism and hyperthyroidism in patients admitted to a geriatric department. Ugeskr Laeger 2001; 163: 5665-8.
Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) 1999; 51: 361-7.
Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2003; 58: 36-42.
D’Herbomez1 M, Jarrige V, Darte C. Reference intervals for serum thyrotropin (TSH) and free thyroxine (FT4) in adults using the Access Immunoassay System Clin Chem Lab Med 2005; 43: 102–5
Groves CJ, Howells RD, Williams S, Darke C, Parkes AB. Primary standardization for the ELISA of serum thyroperoxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population. J Clin Lab Immunol 1990; 32: 147-51.
Kaloumenou I, Mastorakos G, Alevizaki M, Duntas LH, Mantzou E, Ladopoulos C et al. Thyroid autoimmunity in schoolchildren in an area with long-standing iodine sufficiency: correlation with gender, pubertal stage, and maternal thyroid autoimmunity. Thyroid. 2008; 18: 747-54.
Baştemir M, Emral R, Erdoğan G, Güllü S Thyroid. 2006; 16: 1265-71.
Erdoğan MF, Ağbaht K, Altunsu T, Özbaş S, Yücesan F, Tezel B et al. Current iodine status in Turkey. J Endocrinol Invest. 2009; 32: 617-22.
González-Sagrado M, Martín-Gil FJ. Population-specific reference values for thyroid hormones on the Abbott ARCHITECT i2000 analyzer. Clin Chem Lab Med. 2004; 42: 540-2.
Hubl W, Schmieder J, Gladrow E, Demant T. Reference intervals for thyroid hormones on the architect analyser. Clin Chem Lab Med. 2002; 40: 165-6.
Moncayo R, Moncayo H, Virgolini I: Reference values for thyrotropin. Thyroid 2005; 15: 1204-5.
Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005; 51: 1480-6.
Baloch Z, Carayon P, Conte-Devoix B, Demers LM, Feldt- Rasmussen U, Henry JF et al. Laboratory support for the diagnosis and monitoring of disease. Thyroid 2003; 13: 3-126.
Knudsen N, BulowI, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. European Journal of Endocrinology 2000; 143: 485-91.
Jensen E, Hyltoft Petersen P, Blaabjerg O, Hansen PS, Brix TH, Kyvik KO et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clinical Chemistry: Laboratory Medicine 2004; 42: 824-32.
Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001; 86: 4591-9.
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.
Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc 2004; 5: 333- 6.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence study. Archives of Internal Medicine 2000; 160: 526-34.
Brabant G, Beck-Peccoz P, Jarzab B, Laurberg P, Orgiazzi J, Szabolcs I et al. Is there a need to redefine the upper normal limit of TSH? European Journal of Endocrinology 2006; 154: 633-7.